95-10382. National Institutes of Health; Notice of Meeting of the Panel to Assess the NIH Investment in Research on Gene Therapy

[Federal Register Volume 60, Number 81 (Thursday, April 27, 1995)]
[Notices]
[Page 20737]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-10382]



-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Public Health Service


National Institutes of Health; Notice of Meeting of the Panel to 
Assess the NIH Investment in Research on Gene Therapy

    Notice is hereby given that the Panel to Assess the NIH Investment 
in Research on Gene Therapy, a fact-finding group reporting to the 
Advisory Committee to the Director (ACD), National Institutes of Health 
(NIH), will meet in public session at the William H. Natcher Building 
(Building 45) Conference Center, Board Room, National Institutes of 
Health, Bethesda, Maryland 20892, on May 15-16, 1995. The meeting will 
begin at approximately 9:00 a.m. to recess on May 15, and from 
approximately 9:00 a.m. to 1:00 p.m. on May 16.
    The goal of the Panel is to make recommendations to the ACD about 
the scientific areas that NIH should emphasize and the funding 
mechanisms that should be employed in order best to advance the 
development of gene therapy. The purpose of the meeting is to provide 
the Panel with an opportunity to hear presentations regarding the 
current and anticipated research activities relevant to gene therapy 
that are supported by the various components of NIH, and to discuss how 
to proceed with its assessment of NIH's investment in gene therapy.
    Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other special accommodations, should 
contact the person named below in advance of the hearing.
    Attendance may be limited to seat availability. If you plan to 
attend the meeting as an observer or if you wish additional 
information, please contact Ms. Janice Ramsden, National Institutes of 
Health, Shannon Building, Room 235, 1 Center Drive MSC 0159, Bethesda, 
Maryland 20892-0159, telephone [phone], fax [phone], by 
May 10.
Ruth L. Kirschstein,
Deputy Director, NIH.
[FR Doc. 95-10382 Filed 4-26-95; 8:45 am]
BILLING CODE 4140-01-P